Delivery Order SPE2DB20D1109-SPE2DB24FN48D
- Not listed
- This federal contract award is for the delivery of Bridion 200 mg/2 ml vial (2 ml) pharmaceutical products to the Defense Logistics Agency (DLA). The $16,496.67 delivery order contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on February 26, 2024, with a completion date of February 27, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of Bridion 200 mg/2 ml vials to the Defense Logistics Agency (DLA), a major agency within the U.S. Department of Defense. The award, valued at $4,030.17, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, awarded on May 2, 2024, with a completion date of May 3, 2024. The contract does not have a set-aside...
- This federal contract award is for the delivery of BRIDION 500 MG/5 ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,642.30 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 29, 2024. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,240.49 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the efficient procurement of a comprehensive range of...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,038.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award is a Delivery Order valued at $12,999.36 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRIDION 500 MG/5 ML VIAL 5ML medical product, with a completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,308.47 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 30, 2021, with a completion date of December 1, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military and veterans'...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical products. The contract has a firm fixed price of $5,336.36 and a completion date of January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,004.52 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 21, 2024. The contract has a completion date of November 22, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $18,966.80 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2025, with a completion date of May 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN48DDelivery Order
This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $10,740.33, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 23, 2024, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This specific award is a delivery order under that larger IDC. The contract has no set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 1/23/24 |